Hospital-Acquired Infection Control Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Hospital-Acquired Infection Control Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Hospital-Acquired Infection Control Market Size Expected to Be by 2034?
In recent times, the hospital-acquired infection control market has seen steady progression. The market size is projected to expand from $34.59 billion in 2024 to $35.86 billion in 2025, with a compound annual growth rate (CAGR) of 3.7%. The historical growth has been fueled by factors such as rising antibiotic resistance, escalating awareness, strict regulatory measures, the spread of infectious diseases due to globalization, and initiatives taken for patient safety.

Substantial growth is anticipated in the upcoming years for the hospital-acquired infection control market, which is projected to escalate to $44.42 billion in 2029 with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the emergence of multidrug-resistant pathogens, readiness for pandemics, heightened surveillance and monitoring efforts, antimicrobial stewardship programs and worldwide collaborations. Key trends expected in this timeframe encompass the incorporation of real-time location systems (RTLS), the use of artificial intelligence (AI) in surveillance, a pivot towards single-use and disposable devices, a focus on staff education and training, and an increased application of disinfection technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694

What Are the Emerging Segments Within the Hospital-Acquired Infection Control Market?
The hospital-acquired infection control market covered in this report is segmented -

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

What Long-Term Drivers Are Shaping Hospital-Acquired Infection Control Market Trends?
The escalation of COVID-19 cases is anticipated to boost the expansion of the hospital-acquired infection control market in the future. COVID-19 is a viral infection induced by the virus named SARS-CoV-2. The pandemic has resulted in a surge in the demand for hospital-acquired infection control products and services, emphasizing personal hygiene and the manufacture of infection control medical provisions. For example, as per the data from the World Health Organization, an agency of the United Nations based in Switzerland, the global count of COVID-19 cases, as recorded on 8th August 2022, stood at 581.6 million. As such, the escalation of COVID-19 cases is fueling the expansion of the hospital-acquired infection control market.

Who Are the Top Competitors in Key Hospital-Acquired Infection Control Market Segments?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton inson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

What Hospital-Acquired Infection Control Market Trends Are Gaining Traction Across Different Segments?
Key players in the market for hospital-acquired infection control are focusing on the creation of fresh tech solutions such as AI systems, designed to detect sepsis in its early stages. Such systems intend to advance patient prognosis via swift diagnosis and therapeutic action. The AI systems that detect early sepsis utilize high-tech solutions involving artificial intelligence and machine learning algorithms. For example, in April 2024, Prenosis Inc., a medical clinic based in the US, was granted FDA marketing approval for the Sepsis ImmunoScore, an AI-powered system devised to predict sepsis' onset. This life-threatening condition could result in severe complications. The innovative tool aids early detection by analyzing data in real-time, enabling healthcare providers to take quick and efficacious action. The AI integration aims to assist healthcare workers in decision-making rather than replacing them, ultimately leading to improved patient outcomes and a decrease in healthcare expenses.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Which Regions Are Becoming Hubs for Hospital-Acquired Infection Control Market Innovation?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hospital-Acquired Infection Control Market?
2. What is the CAGR expected in the Hospital-Acquired Infection Control Market?
3. What Are the Key Innovations Transforming the Hospital-Acquired Infection Control Industry?
4. Which Region Is Leading the Hospital-Acquired Infection Control Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.